BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36111207)

  • 1. The prevalence and associated predictors for Bethesda III-VI for reporting thyroid cytopathology in Royal Commission Hospital, Kingdom of Saudi Arabia.
    Alyousif H; Adam I; Alamin NA; Sid Ahmed MA; Al Saeed A; Hassoni AH; Musa IR
    Ther Adv Endocrinol Metab; 2022; 13():20420188221122486. PubMed ID: 36111207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
    Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
    Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of the ACR TI-RADS Classification With Bethesda Scoring and Histopathology Risk Stratification of Thyroid Nodules.
    Huang EYF; Kao NH; Lin SY; Jang IJH; Kiong KL; See A; Venkatanarasimha N; Lee KA; Lim CM
    JAMA Netw Open; 2023 Sep; 6(9):e2331612. PubMed ID: 37703017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
    Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
    BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USING THE ATA AND ACR TI-RADS SONOGRAPHIC CLASSIFICATIONS AS ADJUNCTIVE PREDICTORS OF MALIGNANCY FOR INDETERMINATE THYROID NODULES.
    Ahmadi S; Herbst R; Oyekunle T; Jiang X'; Strickland K; Roman S; Sosa JA
    Endocr Pract; 2019 Sep; 25(9):908-917. PubMed ID: 31170369
    [No Abstract]   [Full Text] [Related]  

  • 6. Age-related variation in malignant cytology rates of thyroid nodules: insights from a retrospective observational study assessing the ACR TI-RADS.
    Walter LB; Fernandes PM; Strieder DL; Scheinpflug AL; Zanella AB; Faccin CS; Farenzena M; Xavier LF; Zorzi BDC; Graudenz MS; Scheffel RS; Dora JM; Goemann IM; Maia AL
    Eur J Endocrinol; 2023 Dec; 189(6):584-589. PubMed ID: 38033287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of ACR TI-RADS and the Bethesda System in Predicting Risk of Malignancy in Thyroid Nodules at a Large Children's Hospital and a Comprehensive Review of the Pediatric Literature.
    Hess JR; Van Tassel DC; Runyan CE; Morrison Z; Walsh AM; Schafernak KT
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ACR TI-RADS cytologically indeterminate thyroid nodules and molecular profiles: a single-institutional experience.
    Belovarac B; Zhou F; Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Szeto O; Simsir A; Sheth S; Brandler TC
    J Am Soc Cytopathol; 2022; 11(3):165-172. PubMed ID: 35181254
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zhu Y; Wu H; Huang B; Shen X; Cai G; Gu X
    Gland Surg; 2020 Oct; 9(5):1674-1684. PubMed ID: 33224845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules.
    Alqahtani SM; Al-Sobhi SS; Alturiqy MA; Alsalloum RI; Al-Hindi HN
    J Taibah Univ Med Sci; 2023 Jun; 18(3):506-511. PubMed ID: 36818179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the ultrasound thyroid imaging reporting and data system with cytology findings among patients in Uganda.
    Isse HM; Lukande R; Sereke SG; Odubu FJ; Nassanga R; Bugeza S
    Thyroid Res; 2023 Sep; 16(1):26. PubMed ID: 37653537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of 2017 ACR Thyroid Imaging Reporting and Data System (TI-RADS) combined with fine needle aspiration biopsy in thyroid nodules.
    Zhang C; Huang YQ; Liu ZL
    J Xray Sci Technol; 2021; 29(6):1113-1122. PubMed ID: 34459431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid Cancer Detection in a Routine Clinical Setting: Performance of ACR TI-RADS, FNAC, and Molecular Testing in Prospective Cohort Study.
    Grimmichova T; Pacesova P; Hill M; Pekova B; Vankova M; Moravcova J; Vrbikova J; Novak Z; Mastnikova K; Vaclavikova E; Vcelak J; Bendlova B; Drozenova J; Sykorova V
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using an ultrasonography risk stratification system to enhance the thyroid fine needle aspiration performance.
    Strieder DL; Cristo AP; Zanella AB; Faccin CS; Farenzena M; Graudenz MS; Dora JM; Maia AL; Scheffel RS
    Eur J Radiol; 2022 May; 150():110244. PubMed ID: 35299112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy.
    Al Dawish MA; Alwin Robert A; Thabet MA; Braham R
    Cancer Inform; 2018; 17():1176935118765132. PubMed ID: 29581701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the Number of Unnecessary Thyroid Nodule Biopsies With the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS).
    Abou Shaar B; Meteb M; Awad El-Karim G; Almalki Y
    Cureus; 2022 Mar; 14(3):e23118. PubMed ID: 35425684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic reliability of the Thyroid Imaging Reporting and Data System (TI-RADS) in routine practice.
    Jabar ASS; Koteshwara P; Andrade J
    Pol J Radiol; 2019; 84():e274-e280. PubMed ID: 31482001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Performance of ACR TI-RADS Also Considering Those Nodules with No Indication of FNAC: A Single-Center Experience.
    Amendola S; Wolde Sellasie S; Pedicini F; Carlini M; Russo G; Ossola N; Leoncini A; Botti F; Bonanno E; Trimboli P; Uccioli L
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid imaging reporting and data system score combined with Bethesda system for malignancy risk stratification in thyroid nodules with indeterminate results on cytology.
    Maia FF; Matos PS; Pavin EJ; Zantut-Wittmann DE
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):439-44. PubMed ID: 24930423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy and ability to reduce unnecessary FNAC: A comparison between four Thyroid Imaging Reporting Data System (TI-RADS) versions.
    Tan L; Tan YS; Tan S
    Clin Imaging; 2020 Sep; 65():133-137. PubMed ID: 32470834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.